Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain.
Journal
Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571
Informations de publication
Date de publication:
15 Sep 2020
15 Sep 2020
Historique:
entrez:
15
9
2020
pubmed:
16
9
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.
Substances chimiques
Cryogels
0
Interleukin-13
0
Heparin
9005-49-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4997-5004Subventions
Organisme : Medical Research Council
ID : G1001257
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M02475X/1
Pays : United Kingdom